Viewing Study NCT03911193


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2026-01-25 @ 10:32 AM
Study NCT ID: NCT03911193
Status: UNKNOWN
Last Update Posted: 2019-04-11
First Post: 2019-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation
Sponsor: Fondazione Ricerca Traslazionale
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module